← FDA DRUG APPROVALS

FDA ANDA · ANDA075357

HAIR REGROWTH TREATMENT

minoxidil

Sponsor: L PERRIGO CO

APPLICATION
ANDA075357
TYPE
ANDA
ORIGINAL APPROVAL
1999-07-30
LATEST ACTION
2016-03-30
ROUTE
TOPICAL, EXTRACORPOREAL, CUTANEOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Over-the-counter

Products

MINOXIDIL (FOR WOMEN)Over-the-counter
MINOXIDIL 2% · SOLUTION · TOPICAL
MINOXIDIL (FOR MEN)Over-the-counter
MINOXIDIL 2% · SOLUTION · TOPICAL

Approval history

2016-03-30Labeling · Supplement 24 · standardAP
2008-10-08Labeling · Supplement 14AP
2005-07-14Labeling · Supplement 5AP
1999-07-30OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →